Literature DB >> 26323722

Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4.

Deyao Wu1, Huixing Pan1, Yunfeng Zhou1, Zichun Zhang1, Ping Qu1, Jian Zhou1, Wanxiang Wang2.   

Abstract

MicroRNA-204 (miR-204) has been reported to be frequently downregulated in various types of cancer, including renal, brain, ovary, hematological and colon cancer. The present study, investigated the effects of miR‑204 on renal cell carcinoma. Following transfection of miR‑204, an MTT assay, cell migration assay, cell invasion assay, western blot analysis and luciferase assay were performed in renal cell carcinoma cell lines. It was demonstrated that miR‑204 inhibits cell proliferation, migration and invasion in 786‑O and A498 cells. To the best of our knowledge, this study is the first to demonstrate that miR‑204 directly targets SOX4 in renal cell carcinoma. These results suggested that miR-204 may have value as a marker for the early detection of tumor metastasis and a therapeutic target preventing the invasion of renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26323722     DOI: 10.3892/mmr.2015.4259

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

1.  An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer.

Authors:  Fang Yang; Yan Shen; Wenwen Zhang; Juan Jin; Doudou Huang; Hehui Fang; Wenfei Ji; Yaqin Shi; Lin Tang; Weiwei Chen; Guohua Zhou; Xiaoxiang Guan
Journal:  Cell Death Differ       Date:  2018-05-29       Impact factor: 15.828

2.  Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A.

Authors:  Wanjun Li; Guoyin Li; Zhigang Fan; Tao Liu
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

3.  miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.

Authors:  Zhe Liu; Jin Long; Ruixia Du; Chunlin Ge; Kejian Guo; Yuanhong Xu
Journal:  Tumour Biol       Date:  2016-01-05

4.  MicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2.

Authors:  Bin Hu; Ming Sun; Jiajun Liu; Guolin Hong; Qin Lin
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

5.  Protease activated receptor 2 mediates tryptase-induced cell migration through MYO10 in colorectal cancer.

Authors:  Xiaoli Zhang; Qing Fang; Yiming Ma; Shuangmei Zou; Qian Liu; Hongying Wang
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

6.  microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.

Authors:  Yan Tang; Wei Wan; Lijuan Wang; Shishun Ji; Juanjuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

7.  Characterization and Small RNA Content of Extracellular Vesicles in Follicular Fluid of Developing Bovine Antral Follicles.

Authors:  Raphatphorn Navakanitworakul; Wei-Ting Hung; Sumedha Gunewardena; John S Davis; Wilaiwan Chotigeat; Lane K Christenson
Journal:  Sci Rep       Date:  2016-05-09       Impact factor: 4.379

8.  Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4).

Authors:  Chun-Li Zhou; Jing-Jing Li; Peng Ji
Journal:  Med Sci Monit       Date:  2017-01-24

9.  Comparative Analyses between Skeletal Muscle miRNAomes from Large White and Min Pigs Revealed MicroRNAs Associated with Postnatal Muscle Hypertrophy.

Authors:  Xihui Sheng; Ligang Wang; Hemin Ni; Lixian Wang; Xiaolong Qi; Shuhan Xing; Yong Guo
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

10.  Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia.

Authors:  Aleksandra Butrym; Piotr Łacina; Kazimierz Kuliczkowski; Katarzyna Bogunia-Kubik; Grzegorz Mazur
Journal:  BMC Cancer       Date:  2018-01-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.